2 parallel studies. * For young patients (18-60 years): randomization between CHVP + interferon for 18 months and 4 CHOP followed by autotransplant after TBI * For elderly patients (\>60 years): randomization between CHVP + interferon for 18 months and fludarabine 5 days every months for 6 months
2 parallel studies. * For young patients (18-60 years): randomization between CHVP + interferon for 18 months and 4 CHOP followed by autotransplant after TBI * For elderly patients (\>60 years): randomization between CHVP + interferon for 18 months and fludarabine 5 days every months for 6 months
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
400
Groupe d'atude des lymphome de l'adulte
Yvoir, Belgium
Hôpital Henri Mondor
Créteil, France
Centre Léon Bérard
Lyon, France
Hôpital Saint Louis
Paris, France
Progression-free survival
Overall survival
Toxicity
Response rates
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Service d'Hématologie - Centre Hospitalier Lyon-Sud
Pierre-Bénite, France
Centre Hospitalier Robert Debré
Reims, France
Centre Henri Becquerel
Rouen, France
Institut Gustave Roussy
Villejuif, France